Table 1. Baseline characteristics of all patients.
| Characteristic | Total (N = 659) |
|---|---|
| Age, years | 61.9 ± 11.8 |
| Female | 51.8 |
| BMI (kg/m2) | 22.3 ± 3.4 |
| Normal; BMI <24 (kg/m2) | 71.6 |
| Overweight; 24 ≤ BMI < 30 (kg/m2) | 26.1 |
| Obese; BMI ≥30 (kg/m2) | 2.3 |
| Presence of HBV or HCV (%) | 24.0 |
| DM (%) | 32.8 |
| AST (IU/L) | 17 (14–22) |
| ALT (IU/L) | 13 (10–19) |
| Bilirubin (mg/dL) | 0.3 (0.2–0.4) |
| Albumin (mg/dL) | 4.0 (3.7–4.2) |
| Creatinine (mg/dL) | 10.7 (912–12.2) |
| Platelet (109/L) | 180 (144–216) |
| Stiffness (kPa) | 5.9 (4.6–7.8) |
| HDL–C: <40 mg/dL(male) or <50 mg/dL(female) | 48.3 |
| LDL (mg/dL) | 85.9 ± 30.6 |
| Triglyceride > 150 (mg/dL) | 34.9 |
| Total cholesterol (mg/dL) | 161.8 ± 38.0 |
| Steatosis | |
| No Steatosis (CAP <232.5) (dB/m) | 49.47 |
| Steatosis grade 1 (232.5 ≥CAP <255) (dB/m) | 20.49 |
| Steatosis grade 2 (255 ≥ CAP <290) (dB/m) | 17.00 |
| Steatosis grade 3 (≥290) (dB/m) | 13.05 |
Data are represented as mean ± standard deviation, median (25th–75th percentile), or percentage. BMI, body mass index; DM, diabetes mellitus; ALT, alanine aminotransferase; AST, aspartate aminotransferase; HDL, High-density lipoprotein; LDL, Low-density lipoprotein; CAP, Controlled Attenuation Parameter; HBV, hepatitis B virus; HCV, hepatitis C virus.